Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial ; volume:50 ; number:5 ; year:2019 ; pages:333-344
American journal of nephrology ; 50, Heft 5 (2019), 333-344
- Urheber
-
Bakris, George L.
Agarwal, Rajiv
Anker, Stefan D.
Pitt, Bertram
Ruilope, Luis M.
Nowack, Christina
Kolkhof, Peter
Ferreira, Anna C.
Schloemer, Patrick
Filippatos, Gerasimos
- DOI
-
10.1159/000503713
- URN
-
urn:nbn:de:101:1-2019112723024589725880
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bakris, George L.
- Agarwal, Rajiv
- Anker, Stefan D.
- Pitt, Bertram
- Ruilope, Luis M.
- Nowack, Christina
- Kolkhof, Peter
- Ferreira, Anna C.
- Schloemer, Patrick
- Filippatos, Gerasimos
Ähnliche Objekte (12)
Nonproteinuric diabetic kidney disease
Progranulin and diabetic kidney disease
Vasopressin and Diabetic Kidney Disease
Biomarkers of diabetic kidney disease
The Vascular Disease of Diabetic Kidney Disease
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes
The future of Diabetic Kidney Disease management: reducing the unmet need
Recent advances in diabetic kidney disease
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Apelinergic system in the kidney: implications for diabetic kidney disease
Diabetic Kidney Disease: Challenges, Advances, and Opportunities
New urinary biomarkers for diabetic kidney disease
Nonproteinuric diabetic kidney disease
Progranulin and diabetic kidney disease
Vasopressin and Diabetic Kidney Disease
Biomarkers of diabetic kidney disease
The Vascular Disease of Diabetic Kidney Disease
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes
The future of Diabetic Kidney Disease management: reducing the unmet need
Recent advances in diabetic kidney disease
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Apelinergic system in the kidney: implications for diabetic kidney disease
Diabetic Kidney Disease: Challenges, Advances, and Opportunities
New urinary biomarkers for diabetic kidney disease
Nonproteinuric diabetic kidney disease
Progranulin and diabetic kidney disease
Vasopressin and Diabetic Kidney Disease
Biomarkers of diabetic kidney disease
The Vascular Disease of Diabetic Kidney Disease
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes
The future of Diabetic Kidney Disease management: reducing the unmet need
Recent advances in diabetic kidney disease
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Apelinergic system in the kidney: implications for diabetic kidney disease
Diabetic Kidney Disease: Challenges, Advances, and Opportunities